Streetbeat News

Assets

ACHC

Acadia Healthcare Co (NASDAQ:ACHC) has significantly outperformed the market with an average annual return of 24.92% over the past 5 years, turning a $100 investment into $290.84 today. The company currently has a market capitalization of $7.40 billion.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 2:00 pm

MEDP

Medpace Holdings (NYSE:MEDP) has seen a decrease in short interest, now at 5.04% of its float, down 3.08% from the last report. With 1.02 million shares sold short, it would take about 5.73 days to cover all short positions. This decline in short interest could indicate a more bullish sentiment towards MEDP among investors. Compared to its peers, MEDP has a lower short interest percentage, with the average for its peer group at 5.57%.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 2:00 pm

TSM

TSMC, a leading semiconductor manufacturer, has reportedly not placed orders for high-numerical aperture (High-NA) extreme ultraviolet (EUV) tools. Sources from fab toolmakers suggest that TSMC is unlikely to use this technology for its upcoming 2nm and 1.4nm (A14) process manufacturing.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:58 pm

RVSN

Rail Vision Ltd. (NASDAQ:RVSN), an Israeli technology company, announced receiving a patent approval from the Indian Patent Office for a railway collision avoidance system. This patent, also approved in the US and Japan, covers advanced vision sensor technology for detecting and identifying railway obstacles in real time. The system, which incorporates AI and big data, is seen as a significant advancement for railway safety and operational efficiency, especially in India's vast railway network.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:50 pm

CTLT

NVO

Novo Nordisk A/S (NYSE:NVO) has acquired three fill-finish sites from Novo Holdings A/S for $11 billion, as part of a deal where Novo Holdings acquires Catalent, Inc. (NYSE:CTLT). This acquisition aims to expand Novo Nordisk's manufacturing capacity for diabetes and obesity treatments, with the sites located in Italy, Belgium, and Indiana. The deal, mainly debt-financed, is expected to boost Novo Nordisk's filling capacity from 2026 and aligns with its strategy to enhance treatment accessibility for diabetes and obesity.

Portfolio Pulse from Benzinga Neuro

February 05, 2024 | 1:40 pm

ISPR

Ispire Technology has opened a new manufacturing facility in Malaysia that is ISO- and GMP-certified. This state-of-the-art facility is set to enhance the production of premium vaporizers, cartridges, pod systems, disposables, and batteries for the global vapor industry.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:34 pm

XTKG

X3 Holdings Co., Ltd. (NASDAQ:XTKG) announced a strategic roadmap for global expansion, targeting growth in digital technologies, bitcoin cryptomining, renewable energy, and agriculture technologies. The company plans to expand its digital trade platforms and services globally, develop bitcoin mining operations powered by sustainable energy, and pursue renewable energy projects and agriculture technologies to improve farm operations and reduce costs. CEO Stewart Lor emphasized the transformative journey and the focus on high-growth industries to drive innovation and create value.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:33 pm

CI

The Cigna Group (NYSE:CI) has initiated tender offers to purchase up to $2.25 billion in aggregate principal amount of its outstanding notes. This includes an 'Any and All Tender Offer' for its 3.50% Senior Notes due 2024 and Evernorth Health, Inc.'s 3.50% Senior Notes due 2024, and a 'Maximum Tender Offer' for various notes due between 2025 and 2030, with a maximum amount of $1,250,000,000. The offers are subject to terms and conditions detailed in the Offer to Purchase dated February 5, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:27 pm

DXPE

DXP Enterprises, Inc. (NASDAQ:DXPE) has acquired Kappe Associates, Inc., a leading distributor in the water and wastewater industry, to enhance its National Water & Wastewater efforts and deepen its presence in the Mid-Atlantic region. The acquisition, funded with cash from DXP's balance sheet, is expected to contribute positively to DXP's sales and EBITDA, with Kappe's last twelve months' sales and adjusted EBITDA being approximately $25.4 million and $3.8 million, respectively. This acquisition aligns with DXP's growth strategy and marks its tenth acquisition under its DXP Water efforts.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:20 pm

ACON

Aclarion has announced the completion of recent financing transactions, which have effectively reduced its debt and increased its available cash. This strategic financial maneuver is aimed at strengthening the company's balance sheet and enhancing its financial flexibility for future operations and investments.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:03 pm